1. Home
  2. ZLAB vs USLM Comparison

ZLAB vs USLM Comparison

Compare ZLAB & USLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • USLM
  • Stock Information
  • Founded
  • ZLAB 2013
  • USLM 1948
  • Country
  • ZLAB China
  • USLM United States
  • Employees
  • ZLAB N/A
  • USLM N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • USLM Other Metals and Minerals
  • Sector
  • ZLAB Health Care
  • USLM Industrials
  • Exchange
  • ZLAB Nasdaq
  • USLM Nasdaq
  • Market Cap
  • ZLAB 3.2B
  • USLM 3.6B
  • IPO Year
  • ZLAB 2017
  • USLM N/A
  • Fundamental
  • Price
  • ZLAB $26.35
  • USLM $135.40
  • Analyst Decision
  • ZLAB Buy
  • USLM
  • Analyst Count
  • ZLAB 6
  • USLM 0
  • Target Price
  • ZLAB $57.22
  • USLM N/A
  • AVG Volume (30 Days)
  • ZLAB 613.7K
  • USLM 82.4K
  • Earning Date
  • ZLAB 11-06-2025
  • USLM 10-29-2025
  • Dividend Yield
  • ZLAB N/A
  • USLM 0.18%
  • EPS Growth
  • ZLAB N/A
  • USLM 44.81
  • EPS
  • ZLAB N/A
  • USLM 4.36
  • Revenue
  • ZLAB $427,799,000.00
  • USLM $352,260,000.00
  • Revenue This Year
  • ZLAB $41.80
  • USLM $22.64
  • Revenue Next Year
  • ZLAB $49.93
  • USLM $8.38
  • P/E Ratio
  • ZLAB N/A
  • USLM $30.82
  • Revenue Growth
  • ZLAB 32.56
  • USLM 21.97
  • 52 Week Low
  • ZLAB $23.82
  • USLM $80.47
  • 52 Week High
  • ZLAB $44.34
  • USLM $159.53
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 30.35
  • USLM 64.48
  • Support Level
  • ZLAB $26.07
  • USLM $131.11
  • Resistance Level
  • ZLAB $29.77
  • USLM $137.96
  • Average True Range (ATR)
  • ZLAB 1.21
  • USLM 3.12
  • MACD
  • ZLAB -0.41
  • USLM 0.53
  • Stochastic Oscillator
  • ZLAB 3.54
  • USLM 86.33

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

Share on Social Networks: